Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00499421 · ClinicalTrials.gov registry record
Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 23
- Enrollment target
NCT00499421: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00499421 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00499421 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to evaluate a system for localizing (targeting for treatment) the prostate for external beam radiation therapy. The system will be used to locate the prostate before treatment and to measure movement of the prostate during treatment. The data collected with the system will be compared to CT images taken during the course of your radiation therapy treatment. Researchers will try to use this information to verify the performance of the system, which could lead to improved positioning and tracking of the prostate during treatment.
Primary Outcome
Prostate position determined by center of mass (COM) of prostate. COM calculated by planning system based on contours of prostate on each CT slice. Prostate position assessed as the mean position of the three implanted fiducial markers (MPIF), which is computed using software provided by the commercial fiducial system. These two points (COM and MPIF) expressed using same coordinate system, whose origin is positioned treatment isocenter. Difference between the two points (COM and MPIF) defines a
Interventions
- PROCEDURE Computed Tomography (CT) Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-09-14 |
| Est. Completion | 2023-01-26 |
What the finished NCT00499421 record still lists
NCT00499421 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Computed Tomography (CT) Scan is the first listed.
NCT00499421 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00499421 about?
NCT00499421 is a clinical study titled "Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy". The goal of this clinical research study is to evaluate a system for localizing (targeting for treatment) the prostate for external beam radiation therapy. The system will be used to locate the prostate before treatment and to measure movement of the prostate during treatment. The data collected wit...
What is the current status of trial NCT00499421?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2005-09-14. Estimated completion is 2023-01-26.
What interventions are being tested in trial NCT00499421?
The interventions under investigation include: Computed Tomography (CT) Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00499421?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI